15 16 17 18 19 2 Nutrient deprivation triggers stringent response in bacteria, allowing rapid 20 reallocation of resources from proliferation toward stress survival. Critical to this process 21 is the accumulation/degradation of (p)ppGpp regulated by the RelA/SpoT homologues. 22 While mammalian genomes encode MESH1, a homologue of the bacterial (p)ppGpp 23 hydrolase SpoT, neither (p)ppGpp nor its synthetase has been identified in mammalian 24 cells. Therefore, the function of MESH1 remains a mystery. Here, we report that human 25 MESH1 is an efficient cytosolic NADPH phosphatase, an unexpected enzymatic activity 26 that is captured by the crystal structure of the MESH1-NADPH complex. MESH1 27 depletion promotes cell survival under ferroptosis-inducing conditions by sustaining the 28 level of NADPH, an effect that is reversed by the simultaneous depletion of the cytosolic 29 NAD(H) kinase, NADK, but not its mitochondrial counterpart NADK2. Importantly, 30 MESH1 depletion also triggers extensive transcriptional changes that are distinct from the 31 canonical integrated stress response but resemble the bacterial stringent response, 32
also found in a guanine base, hMESH1 lacks the ability to differentiate the adenine nucleotide 137 from the guanine nucleotide as was found in ppGpp. 138 The ribose ring of the nicotinamide riboside is indirectly recognized by a water mediated 139 hydrogen bond of its ring oxygen atom with R142 of 9, whereas the nicotinamide moiety is 140 supported by a pi-stacking network with W138 and R142 that emanate from the 8-9 loop and 141 from 9 (Fig. 2c,e) . The terminal amide group is additionally buttressed by two hydrogen bonds 142 with H141 and E145 of 9. These structural observations reinforce the notion that hMESH1 is a 143 bona fide NADPH phosphatase. 144 145 MESH1 regulates cellular NADPH levels and ferroptosis 146 After revealing the molecular basis of the NADPH recognition by hMESH1 and 147 establishing hMESH1 as a significant contributor to the cellular NADPH phosphatase activity, 148 we examined the functional impact of manipulating MESH1 in human cells on NADP(H) and 149 ferroptosis. Ferroptosis is an iron-dependent death under oxidative stresses 11 which can be 150 mitigated by a higher concentration of NADPH 12 . As expected, overexpression of wild type 151 hMESH1 (MESH1-WT), but not an enzymatically deficient mutant (MESH1-E65A), 152 significantly lowered intracellular NADP(H) (Extended Data Fig. 3a, b) . However, the 153 reduction of MESH1 expression by RNAi does not statistically alter the NADP(H) steady state 154 level in cells (Extended Data Fig 3c) . We then asked whether MESH1 depletion could regulate 155 8 NADP(H) levels and cell viability when treated with erastin, which is known to diminish 156 intracellular NADP(H) 12, 13 and trigger ferroptosis 11 . We examined the NADPH concentrations of 157 MESH1-silenced human cells before and after treatment with erastin. While erastin treatment 158 dramatically reduced the NADPH level in the control (siNT) cells, the NADPH level was 159 sustained at a significantly higher level in MESH1-silenced (siMESH1) cells ( Fig. 3a) . 160 Accordingly, the RNAi-mediated MESH1-depletion significantly increased cell survival in the 161 presence of erastin over control cells (Fig. 3b) . Such an effect appeared to be general, as MESH1 162 depletion similarly rescued cell death in multiple cell lines under erastin (Extended Data Fig.   163 3d-f). Importantly, the resistance to erastin-induced ferroptosis was eliminated by overexpression 164 of WT MESH1, but not the catalytically compressed E65A mutant of MESH1 ( Fig. 3b) , 165 indicating that the enhanced cell viability is directly associated with the catalytic activity of 166 hMESH1.
167
Because NADPH is a central metabolite, directly assessing the effects of MESH1 on 168 downstream pathways proved difficult. Thus, to further establish that the enhanced cell survival 169 under oxidative stress is due to a higher sustained level of NADPH, but not due to accumulation 170 of an unidentified substrate of hMESH1, we also tested whether the survival advantage of 171 MESH1 depletion is reversed by simultaneous depletion of NAD(H) kinases that convert 172 NAD(H) to NADP(H). Human cells have two NAD kinases, NADK and NADK2, that are 173 predominantly located in cytosol or mitochondria 14,15 , respectively ( Fig. 3c) . As the cytosolic 174 and mitochondrial pools of NADP(H) and NAD(H) are compartmentalized in mammalian cells 175 due to the impermeability of these molecules across the mitochondrial membranes 16 , we 176 reasoned that the removal of the NAD kinase either from the cytosol (NADK) or mitochondria 177 (NADK2) would reduce the distinct pools of NADP(H) and compromise the ferroptosis survival 178 9 phenotypes of MESH1-silenced cells. Indeed, when the gene encoding the cytosolic enzyme 179 NADK was silenced, the survival benefit of silencing MESH1 was largely eliminated ( Fig. 3e-f , 180 Extended Data Fig. 3g ) and the intracellular NADP(H) is largely depleted (Fig. 3g) . In contrast, 181 silencing the gene encoding the mitochondrial enzyme NADK2 did not affect the MESH1-182 mediated ferroptosis survival or NADP(H) ( Fig. 3e-g, Extended Data Fig. 3g) ), suggesting its 183 limited role in this process. Consistent with these observations, we found that MESH1 was 184 predominately enriched in the cytosolic, but not the mitochondrial or nuclear pools of proteins, 185 by fractioning the individual cellular components 17 (Fig. 3d) . Taken together, our results Ontology (GO) analysis of differentially expressed genes showed that repressed pathways relevant to cell cycle progression and DNA replication ( Fig. 4a) , with a 199 striking similarity to those observed in the bacterial stringent response 19,20 and in Mesh1 deficient were validated via rt-qPCR ( Fig. 4b-d ). 203 Interestingly, MESH1-silencing induced the expression of ATF4 (Activating transcription 204 factor 4, also known as cAMP-responsive element binding protein 2) ( Fig. 4e )-a key regulator 205 of the integrated stress response-and its target genes, such as ATF3 (Activating transcription 206 factor 3) and CTH (Cystathionine gamma-lyase) 21 (Fig. 4g, h) , suggesting that MESH1-silencing 207 also triggered a known mammalian stress response. In order to understand the relationship 208 between the MESH1-silencing-induced stress response and the integrated stress response, we 209 simultaneously silenced MESH1 and ATF4 and compared the resulting cellular phenotype and 210 transcriptional changes with those of the MESH1-silenced cells. We found that ATF4-silencing 211 did not alter the stress survival phenotype of MESH1-silenced cells under ferroptosis-inducing 212 conditions ( Fig. 4f) . In addition, while the ATF4-silencing abolished the induction of known 213 ATF4 target genes, including ATF3 and CTH (Fig. 4g, h) , it did not affect the transcriptional 214 profile of other MESH1-silenceing responsive genes such as ACLY (ATP Citrate Lyase) and 215 RRM2 (Fig. 4i, j) . In general, only 24% (124 out of 525 genes) of the MESH1-silencing signature 216 was affected by simultaneous ATF4 silencing ( Fig. 4k) . These data argue that although the 217 MESH1-silencing-induced stress response may function in part through genes in the integrated 218 stress survival pathway, it has a distinct transcriptional profile and regulatory mechanism and 219 functions independently of the integrated stress survival pathway to promote stress survival 220 under ferroptosis-inducing conditions.
221
In summary, we found that MESH1, the metazoan homolog of SpoT, is a cytosolic 222 NADPH phosphatase in human cells. MESH1-silencing preserves NADPH, which contributes to 223 cell survival under ferroptosis-inducing conditions. Although the transcriptional profile of 224 11 MESH1-silenced cells partially overlaps with that of the integrated stress response, the stress 225 survival phenotype of MESH1-silencing is independent of ATF4, a key mediator of the 226 integrated stress response pathway. Given the striking similarity of transcriptional changes 227 caused by MESH1-silencing with that of the bacterial stringent response, we suggest that 228 MESH1 plays a key role in a novel mammalian stress-response pathway that resembles the 229 bacterial stringent response. immunoassay. Anal Biochem 171, 266-270 (1988) . 
